APERDURE Trademark

Trademark Overview


On Monday, November 7, 2005, a trademark application was filed for APERDURE with the United States Patent and Trademark Office. The USPTO has given the APERDURE trademark a serial number of 78748639. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, January 10, 2007. This trademark is owned by Agouron Pharmaceuticals, Inc.. The APERDURE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of macular degeneration, disorders of the eye, cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders and fungal disorders; pharmaceutical preparations namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations
aperdure

General Information


Serial Number78748639
Word MarkAPERDURE
Filing DateMonday, November 7, 2005
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, January 10, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2006

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of macular degeneration, disorders of the eye, cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders and fungal disorders; pharmaceutical preparations namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, January 10, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAgouron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAgouron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Wednesday, January 10, 2007ABANDONMENT - AFTER PUBLICATION
Tuesday, January 9, 2007TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, October 10, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 18, 2006PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2006NOTICE OF PUBLICATION
Friday, June 2, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 19, 2006ASSIGNED TO LIE
Thursday, May 11, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 11, 2006ASSIGNED TO EXAMINER
Monday, November 14, 2005NEW APPLICATION ENTERED IN TRAM